# US 6,726,843 B2 · Inverse chromatography methods and apparatus for evaluation of interactions between modifying agents and receptors comprising natural or artificial mammalian tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,843 B2
- Document ID: US6726843B2
- Status: Granted
- Kind: B2
- Application number: 10/179,573
- Filed: 2002-06-24
- Published: 2003-02-06
- Granted: 2004-04-27
- Earliest claimed: 2001-06-22
- Assignees: Symyx Technologies, Inc.
- Inventors: Miroslav Petro; Ralph B. Nielsen; Jacqueline M. Regan
- Web page: https://patentgrep.com/patent/US6726843B2

## CPC

- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- G01N 30/88: Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N 30/89: Inverse chromatography
- G01N 33/5085: {of invertebrates}
- B01J 2219/00274: Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J 2219/00315: Microtiter plates
- B01J 2219/00317: Microwell devices, i.e. having large numbers of wells
- B01J 2219/00585: Parallel processes
- B01J 2219/00599: Solution-phase processes
- B01J 2219/00707: separated from the reactor apparatus
- B01J 2219/00722: Nucleotides
- B01J 2219/00725: Peptides
- B01J 2219/00731: Saccharides
- B01J 2219/00736: Non-biologic macromolecules, e.g. polymeric compounds
- B01J 2219/00743: Cells
- B01J 2219/00747: Catalysts
- B01J 2219/00752: Alloys
- G01N 30/466: {with separation columns in parallel}
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

Methods and apparatus for the evaluation of interactions between substances using inverse chromatography are disclosed. Preferably, interactions are evaluated between a liquid test sample and a solid phase comprising a receptor in the presence of a liquid carrier. Preferably, one of the modifying agent or receptor are members of a combinatorial library.

## Claims

### Claim 1

A method for evaluating the interaction between a receptor comprising natural or artificial mammalian tissue and a modifying agent in the presence of a liquid carrier, the method comprising:
providing the receptor comprising natural or artificial mammalian tissue, and providing the modifying agent, one of the receptor and modifying agent being provided as a member of a combinatorial library having at least four members,
conducting at least four test procedures with the receptor, modifying agent and liquid carrier being the same in each of the test procedures except that in each test procedure a different member of the combinatorial library is used, each of the test procedures comprising:
(a) injecting a liquid test sample comprising the modifying agent into a stream of the liquid carrier, the injection being carried out over a limited time so that a distinct test section of the stream contains the test sample,
(b) passing the stream of liquid carrier containing the test sample over a solid phase in a test chamber, the solid phase comprising the receptor, and
(c) examining the stream of liquid carrier leaving the test chamber to ascertain a variable which reflects the interaction of the modifying agent and the receptor in the presence of the liquid carrier.

### Claim 2 (depends on 1)

The method according to claim 1 wherein modifying agent comprises a non-biological polymer.

### Claim 3 (depends on 1)

The method according to claim 1 wherein the library is a library of receptors.

### Claim 4 (depends on 1)

The method according to claim 1 wherein the library is a library of receptors, each of the members of the library comprising a different natural or artificial mammalian tissue.

### Claim 5 (depends on 1)

The method according to claim 1 wherein the library is a library of receptors, each of the members of the libraries comprising a same common natural or artificial mammalian tissue that has been pretreated with a different non-biological polymer.

### Claim 6 (depends on 1)

The method according to claim 1 wherein the library is a library of modifying agents.

### Claim 7 (depends on 1)

The method according to claim 1 wherein the library is a library of modifying agents, each of the at least four members of the library comprising a therapeutic agent or a diagnostic agent.

### Claim 8 (depends on 1)

The method according to claim 1 wherein the library is a library of modifying agents, each of the at least four members of the library comprising a different therapeutic agent or a different diagnostic agent.

### Claim 9

A method for evaluating the interaction between a receptor comprising natural or artificial mammalian tissue and a modifying agent comprising a non-biological polymer in the presence of a liquid carrier, the method comprising:
providing the receptor comprising natural or artificial mammalian tissue, and providing the modifying agent comprising a non-biological polymer, the modifying agent being provided as a member of a combinatorial library having at least four members, each of the at least four members of the library comprising a different non-biological polymer,
conducting at least four test procedures with the receptor and liquid carrier being the same in each of the test procedures, and with a different member of the combinatorial library being used in each of the at least four test procedures, each of the test procedures comprising:
(a) injecting a liquid test sample comprising the modifying agent into a stream of the liquid carrier, the injection being carried out over a limited time so that a distinct test section of the stream contains the test sample,
(b) passing the stream of liquid carrier containing the test sample over a solid phase in a test chamber, the solid phase comprising the receptor, and
(c) examining the stream of liquid carrier leaving the test chamber to ascertain a variable which reflects the interaction of the modifying agent and the receptor in the presence of the liquid carrier.

### Claim 10 (depends on 9)

The method according to claim 9 wherein each of the at least four members of the library of modifying agents further comprises a therapeutic agent or a diagnostic agent.

### Claim 11 (depends on 9)

The method according to claim 9 wherein each of the at least four members of the library of modifying agents comprises a different non-biological polymer and either a same common therapeutic agent or a same common diagnostic agent.

### Claim 12 (depends on 1, 9)

The method according to claim 1 or 9 wherein the liquid carrier is water or an aqueous solution.

### Claim 13 (depends on 1, 9)

The method according to claim 1 or 9 wherein the receptor comprises natural mammalian tissue.

### Claim 14 (depends on 1, 9)

The method according to claim 1 or 9 wherein the receptor comprises artificial mammalian tissue.

### Claim 15 (depends on 1, 9)

The method according to claim 1 or 9 further comprising:
(d) using the results from the steps (c) of the test procedures to select at least one member of the library for further testing; and
(e) subjecting the member or members of the library selected in step (d) to further testing.

### Claim 16 (depends on 1, 9)

The method according to claim 1 or 9 wherein the at least four test procedures are conducted in parallel.

### Claim 17 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the efficiency of the test chamber is less than 50 theoretical plates.

### Claim 18 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the efficiency of the test chamber is less than 10 theoretical plates.

### Claim 19 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the test sample comprises an initial quantity of the modifying agent, and at least 10% of the initial quantity of the modifying agent is irreversibly retained on the solid phase in the test chamber under test conditions of the procedures.

### Claim 20 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the test sample comprises an initial quantity of the modifying agent, and 30% to 50% of the initial quantity of the modifying agent is irreversibly retained on the solid phase in the test chamber under test conditions of the procedures.

### Claim 21 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the test sample comprises an initial quantity of the modifying agent, a percentage of the initial quantity of the modifying agent is irreversibly retained on the solid phase in the test chamber under test conditions of the procedures, and the difference between the lowest and highest percentages of the initial quantity of modifying agent retained in the test chamber is at least 10% as compared between the at least four test procedures.

### Claim 22 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the receptor is not saturated by the modifying agent.

### Claim 23 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, a plot of time against concentration of the modifying agent in the stream of liquid carrier leaving the test chamber has only a single peak, with the slope of the plot being positive at all points on one side of the peak and negative at all points after the peak.

### Claim 24 (depends on 1, 9)

The method according to claim 1 or 9 wherein the receptor comprises at least 50% by weight of particles having an aspect ratio of at least 2 and at least one dimension which is greater than 100 micron.

### Claim 25 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, the test sample comprises an initial quantity of the modifying agent and step (c) consists essentially of ascertaining the proportion of the initial quantity which remains in the test section.

### Claim 26 (depends on 1, 9)

The method according to claim 1 or 9 wherein in each of the test procedures, step (c) comprises examining the stream of liquid carrier leaving the test chamber to ascertain a property of the modifying agent which remains in a distinct evaluation section of the stream corresponding to the test section, and the test procedure further comprises:
(d) injecting a liquid reference sample into a stream of the liquid carrier, the composition of the second sample being substantially identical to the composition of the test sample, and the injection being carried out over a limited time so that only a distinct reference section of the stream contains the reference sample,
(e) passing the stream of liquid carrier containing the reference sample through a reference chamber which is free of any substance which interacts with the modifying agent,
(f) examining the stream of liquid carrier leaving the reference chamber to ascertain a property of the modifying agent remaining in the stream, and
(g) comparing the results obtained in steps (c) and (f) to evaluate the interaction between the receptor and the modifying agent.

### Claim 27 (depends on 26)

The method according to claim 26 wherein each of steps (c) and (f) comprises passing the stream of liquid carrier through a detector which measures a property which depends on the concentration of the modifying agent, the measurement being carried out without removing anything from the stream and at intervals which make it possible to ascertain the amount of the modifying agent which remains in the stream.

### Claim 28 (depends on 26)

The method according to claim 26 wherein in each of the test procedures comprising steps (d) to (g), the liquid stream containing the test section and the liquid stream containing the reference section are obtained by
injecting into the stream of liquid carrier a liquid unit whose composition is the same as the composition of the test and reference samples and whose size is equal to the sum of the sizes of the test and reference samples, the injection being carried out over a limited time so that only a distinct section of the liquid stream contains the liquid unit, and
splitting the liquid stream containing the liquid unit into a first sub-stream which passes through the test chamber and includes the test section and a second sub-stream which passes through the reference chamber and includes the reference section.

### Claim 29 (depends on 28)

The method according to claim 28 wherein the liquid stream containing the liquid unit is split into the first and second sub-streams by a flow-splitting junction.

### Claim 30 (depends on 28)

The method according to claim 28 wherein the liquid stream containing the liquid unit is split into the first and second sub-streams by a switching valve.

### Claim 31 (depends on 26)

The method according to claim 26 wherein in each of the test procedures comprising steps (d) to (g), the liquid stream containing the test section and the liquid stream containing the reference section are obtained by
injecting the liquid test sample into a first stream of the liquid carrier, the first stream being contained in a first line in fluid communication with the test chamber so that the first stream containing the test section passes through the test chamber,
injecting the reference sample into a second stream of the liquid carrier, the second stream being contained in a second line in fluid communication with the reference chamber so that the second stream containing the reference section passes through the reference chamber.
